Publisher Correction: Colchicine acts selectively in the liver to induce hepatokines that inhibit myeloid cell activation
Nat Metab
.
2021 May;3(5):728.
doi: 10.1038/s42255-021-00397-5.
Authors
Jui-Hsia Weng
1
,
Peter David Koch
2
3
,
Harding H Luan
4
,
Ho-Chou Tu
5
,
Kenichi Shimada
2
,
Iris Ngan
4
,
Richard Ventura
4
,
Ruomu Jiang
2
,
Timothy J Mitchison
6
Affiliations
1
Department of Systems Biology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.
[email protected]
.
2
Department of Systems Biology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.
3
Center for Systems Biology, Massachusetts General Hospital, Boston, MA, USA.
4
NGM Biopharmaceuticals, South San Francisco, CA, USA.
5
Alnylam Pharmaceuticals, Inc., Cambridge, MA, USA.
6
Department of Systems Biology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.
[email protected]
.
PMID:
33953392
DOI:
10.1038/s42255-021-00397-5
Abstract
A Correction to this paper has been published: https://doi.org/10.1038/s42255-021-00397-5.
Publication types
Published Erratum